Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug;8(2):229-237.
doi: 10.1016/j.ijpddr.2018.04.003. Epub 2018 Apr 12.

The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 2014

Kritpaphat Tantiamornkul  1 , Tepanata Pumpaibool  2 , Jittima Piriyapongsa  3 , Richard Culleton  4 , Usa Lek-Uthai  5
Affiliations

The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 2014

Kritpaphat Tantiamornkul et al. Int J Parasitol Drugs Drug Resist. 2018 Aug.

Abstract

The prevalence of Plasmodium vivax is increasing in the border regions of Thailand; one potential problem confounding the control of malaria in these regions is the emergence and spread of drug resistance. The aim of this study was to determine the genetic diversity in genes potentially linked to drug resistance in P. vivax parasites isolated from four different border regions of Thailand; Thai-Myanmar (Tak, Mae Hong Son and Prachuap Khiri Khan Provinces), and Thai-Cambodian borders (Chanthaburi Province). Isolates were collected from 345 P. vivax patients in 2008 and 2014, and parasite DNA extracted and subjected to nucleotide sequencing at five putative drug-resistance loci (Pvdhfr, Pvdhps, Pvmdr1, Pvcrt-o and Pvk12). The prevalence of mutations in Pvdhfr, Pvdhps and Pvmdr1 were markedly different between the Thai-Myanmar and Thai-Cambodian border areas and also varied between sampling times. All isolates carried the Pvdhfr (58R and 117N/T) mutation, however, whereas the quadruple mutant allele (I57R58M61T117) was the most prevalent (69.6%) in the Thai-Myanmar border region, the double mutant allele (F57R58T61N117) was at fixation on the Thai-Cambodian border (100%). The most prevalent genotypes of Pvdhps and Pvmdr1 were the double mutant (S382G383K512G553) (65.1%) and single mutant (M958Y976F1076) (46.5%) alleles, respectively on the Thai-Myanmar border while the single Pvdhps mutant (S382G383K512A553) (52.7%) and the triple Pvmdr1 mutant (M958F976L1076) (81%) alleles were dominant on the Thai-Cambodian border. No mutations were observed in the Pvcrt-o gene in either region. Novel mutations in the Pvk12 gene, the P. vivax orthologue of PfK13, linked to artemisinin resistance in Plasmodium falciparum, were observed with three nonsynonymous and three synonymous mutations in six isolates (3.3%).

Keywords: Antimalarial drugs; Drug-resistant mutations; Genetic diversity; Plasmodium vivax.

PubMed Disclaimer

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
Prevalence of alleles of the Pvdhfr gene in P. vivax samples collected at four malaria endemic districts of Thailand. The small and big circle represent year 2008 and 2014, respectively. (The two numbers followed each province name represent the numbers of isolates sequenced in 2008, 2014) (bold with underline letters indicate mutant amino acids).
Fig. 2
Fig. 2
Prevalence of alleles of the Pvdhps gene in P. vivax samples collected at four malaria endemic districts of Thailand. The small and big circle represent year 2008 and 2014, respectively. (The two numbers followed each province name represent the numbers of isolates sequenced in 2008, 2014) (bold with underline letters indicate mutant amino acids).
Fig. 3
Fig. 3
Prevalence of alleles of the Pvmdr1 gene in P. vivax samples collected at four malaria endemic districts of Thailand. The small and big circle represent year 2008 and 2014, respectively. (The two numbers followed each province name represent the numbers of isolates sequenced in 2008, 2014) (bold with underline letters indicate mutant amino acids).
Fig. 4
Fig. 4
Distribution and prevalence of tandem repeat variants Pvdhfr collected from Thai-Myanmar and Thai-Cambodian borders. (A) Sequences alignment of Type 1 (wild type, accession no. X98123) and Type 2 amino-acid repeat regions. Dashes (−) represent tandem repeat deletions between amino acid position 82 and 109. Bold underlined letters indicate the tandem repeat. (B) Prevalences of two tandem repeat types obtained from P. vivax isolates from the Thai-Myanmar border (black) and Thai-Cambodian border (blue). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
See this image and copyright information in PMC

References

    1. Ariey F., Witkowski B., Amaratunga C., Beghain J., Langlois A.C., Khim N., Kim S., Duru V., Bouchier C., Ma L., Lim P., Leang R., Duong S., Sreng S., Suon S., Chuor C.M., Bout D.M., Menard S., Rogers W.O., Genton B., Fandeur T., Miotto O., Ringwald P., Le Bras J., Berry A., Barale J.C., Fairhurst R.M., Benoit-Vical F., Mercereau-Puijalon O., Menard D. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–55. - PMC - PubMed
    1. Ashley E.A., Dhorda M., Fairhurst R.M., Amaratunga C., Lim P., Suon S., Sreng S., Anderson J.M., Mao S., Sam B., Sopha C., Chuor C.M., Nguon C., Sovannaroth S., Pukrittayakamee S., Jittamala P., Chotivanich K., Chutasmit K., Suchatsoonthorn C., Runcharoen R., Hien T.T., Thuy-Nhien N.T., Thanh N.V., Phu N.H., Htut Y., Han K.T., Aye K.H., Mokuolu O.A., Olaosebikan R.R., Folaranmi O.O., Mayxay M., Khanthavong M., Hongvanthong B., Newton P.N., Onyamboko M.A., Fanello C.I., Tshefu A.K., Mishra N., Valecha N., Phyo A.P., Nosten F., Yi P., Tripura R., Borrmann S., Bashraheil M., Peshu J., Faiz M.A., Ghose A., Hossain M.A., Samad R., Rahman M.R., Hasan M.M., Islam A., Miotto O., Amato R., MacInnis B., Stalker J., Kwiatkowski D.P., Bozdech Z., Jeeyapant A., Cheah P.Y., Sakulthaew T., Chalk J., Intharabut B., Silamut K., Lee S.J., Vihokhern B., Kunasol C., Imwong M., Tarning J., Taylor W.J., Yeung S., Woodrow C.J., Flegg J.A., Das D., Smith J., Venkatesan M., Plowe C.V., Stepniewska K., Guerin P.J., Dondorp A.M., Day N.P., White N.J., Tracking Resistance to Artemisinin, C Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2014;371:411–423. - PMC - PubMed
    1. Auliff A., Wilson D.W., Russell B., Gao Q., Chen N., Anh le N., Maguire J., Bell D., O'Neil M.T., Cheng Q. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am. J. Trop. Med. Hyg. 2006;75:617–621. - PubMed
    1. Baird J.K. Chloroquine resistance in Plasmodium vivax. Antimicrob. Agents Chemother. 2004;48:4075–4083. - PMC - PubMed
    1. Barnadas C., Ratsimbasoa A., Tichit M., Bouchier C., Jahevitra M., Picot S., Menard D. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Antimicrob. Agents Chemother. 2008;52:4233–4240. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources